Digitization: the end-to-end solution for the decentralization of advanced therapies
Emmanuel Casasola, Annie Prescott, Joseph Higdon
Cell therapy clinical translation: ensuring speed to clinic while mitigating risk
Shreya Shukla, Richard Dennett, Steffany Dunn
Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy
Chesney Michels, Claire Guéguen
Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach
Alex Lei, Sabrina Carmichael
Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies
Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz
Optimizing plasmid DNA purification: strategies for reliable and expandable processes
Christy Franco, Jasmina Puc
Non-viral GMP manufacturing for engineered cells at clinical and commercial scale
Leif Anderson, Chris Abraham